California State Teachers Retirement System (CalSTRS)’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-955
Closed -$733 3130
2025
Q1
$733 Hold
955
﹤0.01% 3046
2024
Q4
$1.22K Hold
955
﹤0.01% 3057
2024
Q3
$1.98K Hold
955
﹤0.01% 3054
2024
Q2
$3.64K Sell
955
-541
-36% -$2.2K ﹤0.01% 3045
2024
Q1
$7.09K Sell
1,496
-953
-39% -$3.71K ﹤0.01% 2962
2023
Q4
$10.5K Sell
2,449
-691
-22% -$2.1K ﹤0.01% 2995
2023
Q3
$9.7K Sell
3,140
-157
-5% -$589 ﹤0.01% 3060
2023
Q2
$14.8K Buy
+3,297
New +$19.7K ﹤0.01% 3081
2022
Q2
Sell
-15,316
Closed -$106K 3267
2022
Q1
$106K Sell
15,316
-1,154
-7% -$10.6K ﹤0.01% 2852
2021
Q4
$205K Buy
16,470
+2,946
+22% +$47.9K ﹤0.01% 2779
2021
Q3
$423K Sell
13,524
-1,415
-9% -$45.8K ﹤0.01% 2514
2021
Q2
$428K Sell
14,939
-8
-0.1% -$285 ﹤0.01% 2735
2021
Q1
$648K Buy
14,947
+1,059
+8% +$70.3K ﹤0.01% 2401
2020
Q4
$994K Buy
+13,888
New +$691K ﹤0.01% 2038

Other funds holding PRLD

California State Teachers Retirement System (CalSTRS)'s PRLD Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Prelude Therapeutics (PRLD) in Q2 2025, closing a stake of 955 shares — an estimated $733 sold.

California State Teachers Retirement System (CalSTRS) first reported a position in PRLD in Q4 2020 and held it in 14 quarters. The position peaked at $994K in Q4 2020. 50 funds tracked by Wall St. Rank hold PRLD as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Prelude Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 955 Prelude Therapeutics shares in Q2 2025, an estimated $733.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Prelude Therapeutics in Q4 2020 and held it in 14 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Prelude Therapeutics position peaked at $994K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.